Mumbai, India

Kota Sridevi

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kota Sridevi. Retrieved from https://idiyas.com/inventor/kota-sridevi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kota Sridevi: Innovator in Pharmaceutical Sciences

Introduction

Kota Sridevi, an accomplished inventor based in Mumbai, India, has made significant contributions to the field of pharmaceutical sciences. His innovative work led to the development of an important patent, showcasing his dedication to advancing healthcare treatments.

Latest Patents

Sridevi holds a patent for Kodaistatins A, B, C, and D, which involves a unique process for their production and utilization. This patent represents a significant step forward in the research and application of these compounds in the pharmaceutical industry.

Career Highlights

Currently, Kota Sridevi works at Aventis Pharma Deutschland GmbH, where he actively contributes to the development of novel pharmaceutical solutions. His role in this distinguished company highlights his expertise and commitment to innovation in the medical field.

Collaborations

Throughout his career, Sridevi has collaborated with notable colleagues, including Nirogi Venkata Ramakrishna and Keshavapura Hosamane Swamy. These partnerships reflect his ability to work with other skilled professionals to achieve groundbreaking results in research and development.

Conclusion

Kota Sridevi's work exemplifies the spirit of innovation in the pharmaceutical industry. With his patent on Kodaistatins and collaboration with esteemed colleagues at Aventis Pharma Deutschland GmbH, he continues to pave the way for advancements in medical treatments that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…